Clinical Trial Update: Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating ITI-1284 as an adjunctive treatment for Generalized Anxiety Disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• ITI-1284

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: RECRUITING